Nick Suzuki is an integral piece of the core and its leader, but he could also be the frontrunner for the Selke Award.
Simply put, Illumina tends to have better profitability ratios compared to its peers. For instance, Illumina has a 68.38% ...
Researchers from the University of Eastern Finland and Aalto University have developed a computational framework called ...
TAPS+ enables simultaneous detection of methylation and genetic variants, unlocking new insights for precision oncology and translational research. Preserves DNA integrity in challenging clinically ...
A cross-continental study suggests that in the treatment of acute myeloid leukemia, age affects survival, independent of genetic-risk groups.
The complexity and heterogeneity of protein therapeutics present significant challenges in biologics discovery, as ...
Long COVID is a heterogeneous clinical condition that affects thousands of people and can manifest in many different ways.
Key market opportunities in the AI-powered rare disease diagnosis domain include leveraging AI for personalized medicine, ...
The first scientific evidence of the Black Death in Edinburgh has been discovered on the remains of a teenage boy who died in ...
Researchers set a new world record for the fastest DNA sequencing, completing a whole genome in under four hours—a ...
The study provides a new perspective: what matters is not only which previous diseases a person has, but also the order in ...